Dynamical analysis of a multi-strain model of HIV in the presence of anti-retroviral drugs

Journal of Biological Dynamics

Volumn 2, Issue 3, 2008, Pages 323-345

  Sharomi, O ^a   Gumel, A B ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Equilibria; HIV strains; Stability; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT;

ALGORITHM; ARTICLE; BIOLOGICAL MODEL; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; PREVALENCE; RISK; SEXUAL BEHAVIOR; SPECIES DIFFERENCE; STATISTICAL MODEL; THEORETICAL MODEL; TREATMENT OUTCOME; VIROLOGY;

ALGORITHMS; ANTI-RETROVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; HIV; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MODELS, THEORETICAL; PREVALENCE; RISK; SEXUAL BEHAVIOR; SPECIES SPECIFICITY; TREATMENT OUTCOME;

EID: 77956203375     PISSN: 17513758     EISSN: 17513766     Source Type: Journal    
DOI: 10.1080/17513750701775599     Document Type: Article

References (29)

1. Blower, S. M., and Volberding, P., 2002. What can modeling tell us about the threat of antiviral drug resistance?. Curr. Opin. Infect. Dis, 15:609–614.
2. Blower, S. M., 2001. Predicting the unpredictable:transmission of drug resistant HIV. Nat. Med, 7 (9):1016–1020.
3. Castillo-Chavez, C., Wenzhang, H., and Jia, L., 1991. Competitive exclusion and co-existence of multiple strains in an SIS STD model. SIAM J. Appl. Math, 5:1790–1811.
4. Dixon, S., McDonald, S., and Roberts, J., 2002. The impact of HIV and AIDS on Africa's economic development. BMJ, 324:232–234.
5. Elbasha, E. H., and Gumel, A. B., 2005. Theoretical assessment of public health impact of imperfect Prophylactic HIV-1 vaccines with therapeutic benefits. Bull. Math. Biol, 68:577–614.
6. Fleck, F., 2004. Developing economies shrink as AIDS reduces workforce. BMJ, 329:. 129
7. Garcia, F., 2004. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J. Acquir. Immune Defic. Syndr, 36 (2):702–713.
8. Group of the Office of AIDS Research Advisory Council, Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents (2006) Available at http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines &Search=Off&GuidelineID=7&ClassID=1
9. Hale, J. K., 1969. Ordinary Differential Equations, New York:John Wiley and Sons.
10. Hethcote, H. W., 2000. The mathematics of infectious diseases. SIAM Rev, 42 (4):599–653.
11. Kgosimore, M., and Lungu, E. M., 2006. The effects of vertical transmission on the spread of HIV/AIDS in the presence of treatment. Math. Biosci. Engr, 3 (2):297–312.
12. Lakshmikantham, V., Leela, S., and Martynyuk, A. A., 1989. Stability Analysis of Nonlinear Systems, New York and Basel:Marcel Dekker, Inc.
13. Lansky, A., Nakashima, A., and Jones, J., 2000. Risk behaviors related to heterosexual transmission from HIV-infected persons. Sex. Transm. Dis, 27:483–489.
14. Lasalle, J. P., The Stability of Dynamical Systems. Regional Conference Series in Applied Mathematics. Philadelphia:SIAM.
15. Law, M. G., 2001. Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS, 15 (10):1287–1294.
16. Lopez, L. F., 2006. A schematic age-structured compartment model of the impact of antiretroviral therapy on HIV incidence and prevalence. Math. Comput. Simulation, 71:131–148.
17. Moore, H., 2005. A mathematical model for treatment-resistant mutations of HIV. Math. Biosci. Eng, 2 (2):363–380.
18. Nicolosi, A., 1994. Risk factors for woman-to-man sexual transmission of the human immunodeficiency virus. J. Acquir. Immun. Defic. Syndr, 7:296–300.
19. O'Brien, T., 1994. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J. Acquir. Immune. Defic. Syndr, 7:705–710.
20. Shiri, T., Garia, W., and Musekwa, S. D., 2005. A two-strain HIV-1 mathematical model to assess the effects of chemotherapy on disease parameters. Math. Biosci. and Engr, 2 (4):811–832.
21. Smith, R. J., and Blower, S. M., 2004. Could disease-modifying HIV vaccine cause population-level pervasity?. Lancet Infect. Dis, 4:636–639.
22. Snchez, M. S., 2005. A decrease in drug resistance levels of the HIV epidemic can be bad news. Bull. Math. Biol, 67 (4):761–782.
23. Travis, C. P., and Blower, S. M., 2000. HIV vaccines:the effect of the mode of action on the co-existence of HIV subtypes. Math. Popul. Stud, 8 (2):205–229.
24. United Nations Department of Economic and Social Affairs/Population Division, The Impact of AIDS, United Nations, New York, 2004
25. van den Driessche, P., and Watmough, J., 2002. Reproduction numbers and subthreshold endemic equilibria for compartmental models of disease transmission. Math. Biosci, 180:29–48.
26. Velasco-Hernandez, J. X., 1994. A model for chagas disease involving transmission by vectors and blood transfusion. Theor. Popul. Biol, 46:1–31.
27. World Bank. 1997. Confronting AIDS:Public Priorities in a Global Epidemic, Oxford:Oxford University Press.
28. World Health Organization. 2003. Scaling up antiretroviral therapy in resource-limited settings:Treatment guidelines for a public health approach. Available at http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf
29. World Health Organization. 2004. The world health report:Changing history, Switzerland:World Health Organization. 1211 Geneva 27